已收盘 10-17 16:00:00 美东时间
+0.870
+0.70%
The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical research.According to a scientific article published in the Archives of Dermatological Research, the model developed by
10-16 19:07
REHOVOT, Israel, Oct. 6, 2025 /PRNewswire/ -- Nova (Nasdaq: NVMI) today announced that its ELIPSON® materials metrology solution has been selected as Tool of Record by a leading global found...
10-06 19:00
CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trialsREHOVOT, Israel, Sept. 30, 2025 /PRNewswire/ -- CollPlant Biotechnologies
09-30 19:04
The latest announcement is out from Hovnanian Enterprises ( ($HOV) ). On Septem...
09-26 04:34
Hovnanian Enterprises ( ($HOV) ) has provided an update. Hovnanian Enterprises ...
09-24 05:12
作者丨欧雪 编辑丨袁斯来 近日,由亚马逊广告与亚马逊全球开店联合推出的系列短视频《水手计划》迎来五周年里程碑,并正式焕新升级为《水手星计划》,已于9月10日起陆...
09-15 10:59
Shares of housing-related stocks are trading higher, possibly amid rate cut hop...
09-12 03:42
Hovnanian Enterprises, Inc. announced the pricing of $450 million Senior Notes at 8.000% due 2031 and $450 million Senior Notes at 8.375% due 2033 for its subsidiary, K. Hovnanian Enterprises, Inc. Proceeds will be used to redeem existing secured notes, repay term loans, and cover related expenses. The Notes are being offered to qualified institutional buyers and in offshore transactions.
09-11 20:15
Hovnanian Enterprises (NYSE:HOV) on Wednesday said its wholly owned subsidiary, K. Hovnanian Enterprises intends to offer $450 million aggregate principal amount of Senior Notes due 2031 and $450 mill...
09-10 20:11